SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-01-500294
Filing Date
2001-07-03
Accepted
2001-07-03 00:00:00
Documents
4

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A s13ga_070301-discovery.txt SC 13G/A 4752
2 JOINT FILING AGREEMENT ex1-1_070301discovery.txt EX-1.1 1839
3 STATEMENT OF CONTROL PERSON ex2-1_070301discovery.txt EX-2.1 942
4 EXHIBIT 3.1 ex3-1_070301discovery.txt EX-3.1 22532
  Complete submission text file 0000947871-01-500294.txt   32566
Mailing Address 350 MAIN STREET SUITE 307 DOYLESTOWN PA 18901
Business Address 350 MAIN STREET SUITE 307 DOYLESTOWN PA 18901 2152404699
DISCOVERY LABORATORIES INC /DE/ (Subject) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-52027 | Film No.: 1674612
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 41 MADISON AVENUE 40TH FLOOR NEW YORK NY 10010 2126850800
ORBIMED ADVISERS INC /CT (Filed by) CIK: 0001033248 (see all company filings)